Home » Newsletters » BioWorld Science

BioWorld Science

June 1, 2005

View Archived Issues

New data on the efficacy of diindolemethane in cervical neoplasia

CaMKII inhibition: potential cardioprotective strategy against structural heart disease

Favorable results for GW-6604 from preclinical models of liver fibrosis

Clinical evidence for the benefits of sildenafil citrate in PAH

MEDI-524 reported safe in children at high risk of RSV infection

IMT-504 stimulates immune response to vaccines in preclinical models

MHLW recommends approval of Mylotarg and Salagen

Tentative approval for Biovail's Zolpidem ODT

Rectogesic launched in U.K.

Enrollment begins in NOBORI 1 study of drug-eluting coronary stent

Avantogen, new name for Australian Cancer Technology

Organon obtains license for Merck's novel oral contraceptive

Vicuron files amendment to anidulafungin NDA

Serono profiles latest events

In vivo efficacy of atiprimod in SCID models of MM

Treatments for erectile dysfunction investigated for asthma

In vivo data demonstrates that CVT-6883 may be useful for chronic lung diseases

New therapeutics for cancer disclosed in recent patents

Ranbaxy receives tentative approval for lamivudine tablets

New agents claimed for the treatment of diabetes

Priority review for Remicade for ulcerative colitis

Preclinical data for BXL-6285 in interstitial cystitis models

Neumune IND filed in U.S.

Pfizer responds to claims linking Viagra to NAION

(-)-BPAP HCL protects cells from hypoxia-induced injury

Titrated pramlintide benefits patients with type 1 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...